Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nexalin Technology, Inc.NXL · Entity 8197 | Sr. VP - Quality - Regulatory | December 19, 2025 | December 23, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nexalin Technology, Inc.
Report date December 19, 2025 · Filed December 23, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)*SEC Table II · derivative / convertible security · Conversion / exercise price $0.83 · Expires 2030-12-19 | Direct | 210,620 |
Reported balance
After 2025-12-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-19 · Grant · Acquired 100,000 · Balance 210,620 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 19, 2025 Filed Dec 23, 2025 09:40 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | GrantStock Option (right to buy)* · Derivative | 100,000 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001829126-25-010252 · ownership.xml · derivative · entry 1 Shelton Carolyn Hamby · CIK 0002053473 · Sr. VP - Quality - Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,620 Underlying: Common Stock · 100,000 shares Expires 2030-12-19 Read SEC document |
| September 12, 2025 Filed Sep 12, 2025 17:09 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001829126-25-007374 · ownership.xml · derivative · entry 1 Shelton Carolyn Hamby · CIK 0002053473 · Sr. VP - Quality - Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,620 Underlying: Common Stock · 20,000 shares Expires 2029-12-27 F1 · derivative.exercise_date: The reporting person was granted an option to purchase 20,000 shares of common stock. The option vests in three equal annual installments for each of the annual periods ending December 27, 2025, 2026 and 2027. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 16:52 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | PurchaseCommon Stock | 6,000 | $2.20 | $13,200.00 |
DisclosureSEC source: 0001829126-25-001766 · ownership.xml · nonDerivative · entry 1 Shelton Carolyn Hamby · CIK 0002053473 · Sr. VP - Quality, Regulatory 10b5-1 filing: No plan indicated Ownership: Indirect · By Husband Disclosed balance after: 30,000 F1 · balance_after: Includes 24,000 shares owned directly by Reporting Person. Read SEC document |
| November 07, 2024 Filed Feb 10, 2025 18:21 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | GrantStock Option (right to buy) · Derivative | 90,620 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001829126-25-000849 · ownership.xml · derivative · entry 3 Shelton Carolyn Hamby · CIK 0002053473 · Senior VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,620 Underlying: Common Stock · 90,620 shares Expires 2029-09-25 F2 · derivative.exercise_date: The reporting person was granted an option to purchase 90,620 shares of common stock. The option vests in three equal annual installments based on the satisfaction of certain performance criteria for each of the annual periods ending September 16, 2025, 2026 and 2027. Read SEC document |
| October 14, 2024 Filed Feb 10, 2025 18:21 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | PurchaseCommon stock | 24,000 | $0.85 | $20,400.00 |
DisclosureSEC source: 0001829126-25-000849 · ownership.xml · nonDerivative · entry 1 Shelton Carolyn Hamby · CIK 0002053473 · Senior VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 F1 · kind: Represents shares purchased after appointment as Senior Vice President, Quality, Regulatory and Clinical Affairs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.